Do DHCR7 rs12785878 and CYP2R1 rs10741657 variants lower circulating 25-hydroxyvitamin D levels?

Genetic research into the determinants of vitamin D status has consistently identified specific single-nucleotide polymorphisms (SNPs) as primary factors influencing circulating levels of 25-hydroxyvitamin D [25(OH)D]. The variants rs12785878 (DHCR7/NADSYN1) and rs10741657 (CYP2R1) are two of the most robustly validated genetic markers in this pathway.

Clinical and genetic evidence

Large-scale genome-wide association studies (GWAS) and meta-analyses have repeatedly confirmed that specific alleles at these two loci are associated with lower serum 25(OH)D concentrations.

• DHCR7/NADSYN1 (rs12785878): The risk allele at this locus is consistently associated with a reduction in serum 25(OH)D, with effect sizes typically ranging from 0.5 to 3 nmol/L per allele. This association holds across diverse ethnic groups, including European, Chinese, and Indian populations.
• CYP2R1 (rs10741657): The G allele (risk variant) is a major determinant of vitamin D deficiency. Studies have shown significant clinical impact; for example, carriers of the risk genotype in certain cohorts demonstrated nearly five times higher odds of vitamin D deficiency (OR 4.844). This effect persists even when considering external factors like sun exposure or athletic training status.

Mechanistic pathways

The influence of these variants is explained by their roles in the biochemical synthesis and metabolism of vitamin D:

• Precursor Availability (DHCR7): The DHCR7 gene encodes 7-dehydrocholesterol reductase. This enzyme converts 7-dehydrocholesterol (7-DHC) into cholesterol. Because 7-DHC is also the immediate precursor to vitamin D3 (via UVB exposure), higher DHCR7 activity effectively "shunts" the precursor away from vitamin D synthesis. The rs12785878 variant modulates this enzymatic competition, reducing the substrate available for vitamin D production.
• Hepatic Hydroxylation (CYP2R1): The CYP2R1 gene encodes the liver’s microsomal vitamin D 25-hydroxylase, which performs the rate-limiting step of converting vitamin D3 into its circulating form, 25(OH)D. The rs10741657 variant influences CYP2R1 mRNA expression and enzyme efficiency, directly limiting the rate at which the liver can activate vitamin D.

Bottom line

The DHCR7 rs12785878 and CYP2R1 rs10741657 variants are strongly associated with lower circulating 25(OH)D levels. They act by reducing the availability of the vitamin D precursor in the skin and impairing the rate-limiting hydroxylation step in the liver, respectively.